The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Previous Investigations Other Litigations Seroquel Research Center Learn More Seroquel Online Resource Seroquel Medication

A Bad Drug?

in this section: A Bad Drug?


Bookmark This Page Print This Page Email This Page

Seroquel - A Bad Drug?

Is Seroquel a bad drug? Recently, links have been found between Seroquel and diabetes, hyopglycemia, pancreatitis, and signifigant weight gain.

Seroquel is primarily used as a treatment for schizophrenia and bipolar disorder, but is also used off-label for anxiety and sleeping disorders.

DID YOU KNOW?
Men with diabetes have 3.1 more lost workdays a year than men without diabetes. Women with diabetes had 0.6 more lost workdays, on average, than those without diabetes.

Weitz & Luxenberg is no longer accepting Seroquel cases.


see also:

A Bad Drug? Seroquel - A Bad Drug? Treatment for disorders with dangerous risks
Is Seroquel a bad drug? Linked to Diabetes, Hypoglycemia, Pancreatitis

Dangers of Seroquel Dangers of Seroquel- Diabetes, Hypoglycemia, Pancreatitis, Weight Gain
Learn about the dangers of Seroquel and the impact on your Health

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims